시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 페닐레프린(Phenylephrine) 의약품 시장 보고서(2025년)
Phenylephrine Drugs Global Market Report 2025
상품코드 : 1769708
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,310,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,121,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,932,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

페닐레프린 의약품 시장 규모는 향후 수 년간 강력한 성장이 전망될 예정입니다. 이러한 미래 성장에 기여하는 요인으로는 개발도상국의 의료비 지출 증가, 중환자실에서 저혈압 치료에 대한 적용 확대, 고령화 인구 증가, 비강 관리에 대한 대중의 인식 향상, 그리고 병용 요법 옵션의 광범위한 채택 등이 있습니다. 예측 기간 중에 예상되는 현저한 동향에는 비강 전달 기술의 혁신, 약제 제제의 안정성의 향상, 비강 스프레이 기술의 진보, 약제와 디바이스의 조합의 통합, 시판약 사용을 위한 디지털 감시 솔루션 등이 있습니다.

호흡기 질환의 이환율 증가는 향후 수년간 페닐레프린 의약품 시장의 성장을 가속할 것으로 예측됩니다. 호흡기 질환은 호흡에 관여하는 폐와 기도를 포함하여 호흡기에 영향을 미치는 모든 질환을 말합니다. 이 질병 증가에 크게 기여하는 것은 대기 오염이며 대기 오염은 폐 조직을 손상시키고 호흡 기능을 손상시키고 천식과 같은 질병을 유발합니다. 페닐레프린 의약품은 코의 충혈제거제로 작용하여 호흡기 질환의 증상을 완화합니다. 그들은 비강 내 혈관을 수축시켜 부기를 줄이고 공기 흐름을 향상시켜 코막힘, 부비동 압력, 감기, 알레르기, 부비동 감염과 관련된 호흡 곤란과 같은 증상을 완화합니다. National Asthma Council은 2022년 호주에서 467명의 천식 관련 사망(여성 299명, 남성 168명)이 기록되어 2021년 355명에서 증가했다고 보고했습니다.

페닐레프린 의약품 시장에서 사업을 전개하는 주요 기업은 편의성 향상, 준비 시간 단축, 환자 안전성 향상을 위해 Ready-to-use 바이알 등의 혁신적인 제제에 주력하고 있습니다. 이러한 바이알은 투여 미스를 줄이고 긴급한 약물 투여를 가속화하고 일관된 약물의 효능과 무균성을 확보하는데 도움이 됩니다. Hikma Pharmaceuticals PLC는 곧 사용할 수 있는 페닐레프린 염산염 주사제 USP를 IMMPHENTIV의 상품명으로 미국에서 발매했습니다. 이 제품은 500mcg/5mL 및 1,000mcg/10mL 바이알로 제공되며, 미국에서 FDA 승인을 받은 최초의 1,000mcg/10mL 제형입니다. 이 제품은 마취 중 혈관 확장을 통해 임상적으로 심각한 저혈압을 경험하는 성인의 혈압을 높이는 것을 목표로하며, 투약 실수를 줄이고 환자의 안전을 지원하는 표준화된 희석 옵션을 병원에 제공합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Phenylephrine drugs are formulations that include phenylephrine, a synthetic sympathomimetic amine widely utilized as a decongestant, vasopressor, and mydriatic agent. It acts by stimulating alpha-1 adrenergic receptors, resulting in vasoconstriction (narrowing of blood vessels), which helps reduce nasal swelling, raise blood pressure, or dilate pupils, depending on how the drug is administered and its intended therapeutic purpose.

Phenylephrine drug products are primarily available in forms such as tablets, syrups, eye drops, and others. Tablets, being solid and portable dosage forms, offer accurate dosing and ease of consumption. They are commonly used to treat conditions like colds, nasal congestion, allergic reactions, eye disorders, and more. These medications can be taken orally or via parenteral routes and are distributed through a range of channels including hospital pharmacies, retail drugstores, and online platforms.

The phenylephrine drugs market research report is one of a series of new reports from The Business Research Company that provides phenylephrine drugs market statistics, including phenylephrine drugs industry global market size, regional shares, competitors with an phenylephrine drugs market share, detailed phenylephrine drugs market segments, market trends and opportunities, and any further data you may need to thrive in the phenylephrine drugs industry. The phenylephrine drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The phenylephrine drugs market size has grown rapidly in recent years. It will grow from $25.44 billion in 2024 to $28.03 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. Key drivers of this historical growth include the increased incidence of cold and flu, a surge in allergic rhinitis cases, a rising preference for over-the-counter treatment options, the expanding trend of self-medication, and a higher volume of surgical interventions.

The phenylephrine drugs market size is expected to see strong growth in the next few years. It will grow to $40.83 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. Factors contributing to this future growth include greater healthcare spending in developing nations, expanded application in treating hypotension in critical care settings, a growing aging population, enhanced public awareness regarding nasal care, and wider adoption of combination therapy options. Prominent trends anticipated in the forecast period include innovations in nasal delivery technologies, enhancements in drug formulation stability, progress in nasal spray technologies, integration of drug-device combinations, and digital monitoring solutions for over-the-counter drug usage.

The rising incidence of respiratory diseases is expected to drive the growth of the phenylephrine drugs market in the coming years. Respiratory diseases refer to any conditions that affect the respiratory system, including the lungs and airways involved in breathing. A significant contributor to the increase in these diseases is air pollution, which damages lung tissue, impairs respiratory function, and triggers illnesses such as asthma. Phenylephrine drugs alleviate symptoms of respiratory diseases by acting as nasal decongestants. They constrict blood vessels in the nasal passages, which reduces swelling and enhances airflow, thereby relieving symptoms like nasal congestion, sinus pressure, and breathing difficulties associated with colds, allergies, and sinus infections. For example, in November 2023, the National Asthma Council, an Australia-based non-profit organization, reported that in 2022, Australia recorded 467 asthma-related deaths, including 299 females and 168 males, an increase from 355 deaths in 2021. Thus, the increasing incidence of respiratory diseases contributes significantly to the growth of the phenylephrine drugs market.

Major companies operating in the phenylephrine drugs market are focusing on innovative formulations, such as ready-to-use vials, to improve convenience, reduce preparation time, and enhance patient safety. Ready-to-use vials contain pre-mixed, pre-measured drug solutions that are immediately ready for administration, eliminating the need for further dilution or preparation. These vials help reduce dosing errors, speed up drug administration in emergency settings, and ensure consistent drug potency and sterility. For instance, in December 2023, Hikma Pharmaceuticals PLC, a UK-based pharmaceutical company known for manufacturing generic injectable and oral formulations, launched its ready-to-use Phenylephrine HCl Injection, USP, in the U.S. under the brand name IMMPHENTIV. This product is available in 500 mcg/5 mL and 1,000 mcg/10 mL vials and is the first FDA-approved 1,000 mcg/10 mL formulation in the U.S. It is intended to raise blood pressure in adults experiencing clinically significant hypotension due to vasodilation during anesthesia, offering hospitals a standardized, pre-diluted option to reduce medication errors and support patient safety.

In June 2022, Dr. Reddy's Laboratories Ltd., an India-based pharmaceutical company, acquired generic injectable products from Eton Pharmaceuticals Inc. for an undisclosed sum. The acquisition was aimed at expanding and strengthening Dr. Reddy's institutional business in the U.S. by adding affordable injectable medications with limited competition that address critical care needs. This move enhances patient access to essential products. Eton Pharmaceuticals Inc., a U.S.-based pharmaceutical company, specializes in the development and commercialization of phenylephrine-based medications.

Major players in the phenylephrine drugs market are Pfizer Inc., Procter And Gamble Co., Johnson And Johnson Consumer Inc, Bayer AG, GlaxoSmithKline PLC, Sandoz Group AG, Hikma Pharmaceuticals USA, Siegfried AG, Perrigo Company PLC, Amneal Pharmaceuticals LLC, Civica, Xellia Pharmaceuticals USA LLC, Camber Pharmaceuticals, Exela Pharma Sciences, Eton Pharmaceuticals, SOLA Pharmaceuticals, Fresenius Kabi USA, Somerset Therapeutics, Meitheal Pharmaceuticals, Novadoz Pharmaceuticals LLC

North America was the largest region in the phenylephrine drugs market in 2024. The regions covered in phenylephrine drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the phenylephrine drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The phenylephrine drugs market consists of sales of oral decongestant tablets, sudafed PE, neo-synephrine, and phenylephrine HCl injection. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Phenylephrine Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on phenylephrine drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for phenylephrine drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The phenylephrine drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Phenylephrine Drugs Market Characteristics

3. Phenylephrine Drugs Market Trends And Strategies

4. Phenylephrine Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Phenylephrine Drugs Growth Analysis And Strategic Analysis Framework

6. Phenylephrine Drugs Market Segmentation

7. Phenylephrine Drugs Market Regional And Country Analysis

8. Asia-Pacific Phenylephrine Drugs Market

9. China Phenylephrine Drugs Market

10. India Phenylephrine Drugs Market

11. Japan Phenylephrine Drugs Market

12. Australia Phenylephrine Drugs Market

13. Indonesia Phenylephrine Drugs Market

14. South Korea Phenylephrine Drugs Market

15. Western Europe Phenylephrine Drugs Market

16. UK Phenylephrine Drugs Market

17. Germany Phenylephrine Drugs Market

18. France Phenylephrine Drugs Market

19. Italy Phenylephrine Drugs Market

20. Spain Phenylephrine Drugs Market

21. Eastern Europe Phenylephrine Drugs Market

22. Russia Phenylephrine Drugs Market

23. North America Phenylephrine Drugs Market

24. USA Phenylephrine Drugs Market

25. Canada Phenylephrine Drugs Market

26. South America Phenylephrine Drugs Market

27. Brazil Phenylephrine Drugs Market

28. Middle East Phenylephrine Drugs Market

29. Africa Phenylephrine Drugs Market

30. Phenylephrine Drugs Market Competitive Landscape And Company Profiles

31. Phenylephrine Drugs Market Other Major And Innovative Companies

32. Global Phenylephrine Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Phenylephrine Drugs Market

34. Recent Developments In The Phenylephrine Drugs Market

35. Phenylephrine Drugs Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기